Investor Relations :: Irwin Naturals, Inc. (IWIN)

Nature's Secret

Microdose Psychedelic Capital Conference

View Event View All Events

Latest Presentations

View Presentation

Investor Presentation

View Presentation

Investor Presentation [Two Pager]

May 25, 2022

Klee Irwin Presenting at Psychedelic Capital

View Press Release

May 24, 2022

Irwin Naturals Expands Licensing Footprint for Branded THC Products to Ohio

May 20, 2022

Irwin Naturals Completes Acquisition of Ketamine Health Centers

View All News

Forbes: Herbal Supplement Giant To Enter THC, Psychedelics Industries, Seeking To Become First Household Brand To Do So

3 Psychedelic Industry Predictions for 2022

Psychedelic Capital: Public vs. Private Markets

Irwin Naturals Begins Rollup Of Psychedelic Mental Health Clinics, It Will Buy Midwest Ketafusion

The Making of a Cult Brand

Latest Financial Results

FY 2021

Fiscal Year Ended Dec 31, 2021

Earnings Release

Earnings Webcast

Combined Consolidated Financial Statements

IR Contacts

Company

Irwin Naturals, Inc.
5310 Beethoven Street
Los Angeles, CA 90066
Toll-Free: 888-223-1548

Investor Relations

Irwin Naturals Investor Relations
Cassandra Bassanetti-Drumm
T: 310-306-3636
investors@irwinnaturals.com

Transfer Agent

Odyssey Trust Company